Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Alfred

Showing results (291-300 of 434) with videos related to

Pageof 44
Sort By:
European Urology Oncology|September 26, 2024
Risk of progression in patients with primary T1 high grade non-muscle invasive bladder cancer - a contemporary cohortOlga M Pijpers, Lisa M C van Hoogstraten, Sebastiaan Remmers, et al.
European Urology|August 22, 2006
Gene expression analysis for the prediction of recurrence in patients with primary Ta urothelial cell carcinomaIman J Schultz, Kenneth Wester, Huub Straatman, et al.
Investigative Radiology|January 16, 2007
Standardized threshold approach using three-dimensional proton magnetic resonance spectroscopic imaging in prostate cancer localization of the entire prostateJurgen J Fütterer, Tom W J Scheenen, Stijn W T P J Heijmink, et al.
Current Pain and Headache Reports|April 20, 2024
Peripheral Nerve Stimulation in Postoperative Analgesia: A Narrative ReviewAlan D Kaye, Taylor R Plaisance, Summer A Smith, et al.
Future Oncology (London, England)|May 19, 2021
Perioperative pembrolizumab therapy in muscle-invasive bladder cancer: Phase III KEYNOTE-866 and KEYNOTE-905/EV-303Matthew D Galsky, Christopher J Hoimes, Andrea Necchi, et al.
BJU International|March 7, 2016
Increasing age is not associated with toxicity leading to discontinuation of treatment in patients with urothelial non-muscle-invasive bladder cancer randomised to receive 3 years of maintenance bacille Calmette-Guérin: results from European Organisation for Research and Treatment of Cancer Genito-Urinary Group study 30911Jorg R Oddens, Richard J Sylvester, Maurizio A Brausi, et al.
European Urology|October 23, 2017
Predicting Response to Intravesical Bacillus Calmette-Guérin Immunotherapy: Are We There Yet? A Systematic ReviewAshish M Kamat, Roger Li, Michael A O'Donnell, et al.
European Urology|June 21, 2014
The effect of age on the efficacy of maintenance bacillus Calmette-Guérin relative to maintenance epirubicin in patients with stage Ta T1 urothelial bladder cancer: results from EORTC genito-urinary group study 30911Jorg R Oddens, Richard J Sylvester, Maurizio A Brausi, et al.
International Journal of Radiation Oncology, Biology, Physics|November 28, 2008
Changes in prostate shape and volume and their implications for radiotherapy after introduction of endorectal balloon as determined by MRI at 3TStijn W T P J Heijmink, Tom W J Scheenen, Emile N J T van Lin, et al.
International Journal of Cancer|May 25, 2006
Prediction of recurrence in Ta urothelial cell carcinoma by real-time quantitative PCR analysis: a microarray validation studyIman J Schultz, Kenneth Wester, Huub Straatman, et al.
Pageof 44

Showing results (291-300 of 434) with videos related to

Sort By:
Pageof 44
European Urology Oncology|September 26, 2024
Risk of progression in patients with primary T1 high grade non-muscle invasive bladder cancer - a contemporary cohortOlga M Pijpers, Lisa M C van Hoogstraten, Sebastiaan Remmers, et al.
European Urology|August 22, 2006
Gene expression analysis for the prediction of recurrence in patients with primary Ta urothelial cell carcinomaIman J Schultz, Kenneth Wester, Huub Straatman, et al.
Investigative Radiology|January 16, 2007
Standardized threshold approach using three-dimensional proton magnetic resonance spectroscopic imaging in prostate cancer localization of the entire prostateJurgen J Fütterer, Tom W J Scheenen, Stijn W T P J Heijmink, et al.
Current Pain and Headache Reports|April 20, 2024
Peripheral Nerve Stimulation in Postoperative Analgesia: A Narrative ReviewAlan D Kaye, Taylor R Plaisance, Summer A Smith, et al.
Future Oncology (London, England)|May 19, 2021
Perioperative pembrolizumab therapy in muscle-invasive bladder cancer: Phase III KEYNOTE-866 and KEYNOTE-905/EV-303Matthew D Galsky, Christopher J Hoimes, Andrea Necchi, et al.
BJU International|March 7, 2016
Increasing age is not associated with toxicity leading to discontinuation of treatment in patients with urothelial non-muscle-invasive bladder cancer randomised to receive 3 years of maintenance bacille Calmette-Guérin: results from European Organisation for Research and Treatment of Cancer Genito-Urinary Group study 30911Jorg R Oddens, Richard J Sylvester, Maurizio A Brausi, et al.
European Urology|October 23, 2017
Predicting Response to Intravesical Bacillus Calmette-Guérin Immunotherapy: Are We There Yet? A Systematic ReviewAshish M Kamat, Roger Li, Michael A O'Donnell, et al.
European Urology|June 21, 2014
The effect of age on the efficacy of maintenance bacillus Calmette-Guérin relative to maintenance epirubicin in patients with stage Ta T1 urothelial bladder cancer: results from EORTC genito-urinary group study 30911Jorg R Oddens, Richard J Sylvester, Maurizio A Brausi, et al.
International Journal of Radiation Oncology, Biology, Physics|November 28, 2008
Changes in prostate shape and volume and their implications for radiotherapy after introduction of endorectal balloon as determined by MRI at 3TStijn W T P J Heijmink, Tom W J Scheenen, Emile N J T van Lin, et al.
International Journal of Cancer|May 25, 2006
Prediction of recurrence in Ta urothelial cell carcinoma by real-time quantitative PCR analysis: a microarray validation studyIman J Schultz, Kenneth Wester, Huub Straatman, et al.
Pageof 44